RNA Structures as Mediators of Neurological Diseases and as Drug Targets.
about
Chemical Tools for Dissecting the Role of lncRNAs in Epigenetic RegulationCharacterization and in vitro activity of a branched peptide boronic acid that interacts with HIV-1 RRE RNAAdvancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.Diagnostic and therapeutic potential of microRNAs in neuropsychiatric disorders: Past, present, and future.Smart micelleplexes as a new therapeutic approach for RNA delivery.Myotonic dystrophy: approach to therapy.Fast, clash-free RNA conformational morphing using molecular junctions.RNA metabolism is the primary target of formamide in vivo.Proton-detected solid-state NMR detects the inter-nucleotide correlations and architecture of dimeric RNA in microcrystals.RNA-binding proteins in neurodegeneration: mechanisms in aggregate.An l-RNA Aptamer with Expanded Chemical Functionality that Inhibits MicroRNA Biogenesis.Discovery of Key Physicochemical, Structural, and Spatial Properties of RNA-Targeted Bioactive Ligands.Targeting RNA G-quadruplexes as new treatment strategy for C9orf72 ALS/FTD.Natural History of Spinocerebellar Ataxia Type 31: a 4-Year Prospective Study.Towards Long-Range RNA Structure Prediction in Eukaryotic Genes.SMMDB: a web-accessible database for small molecule modulators and their targets involved in neurological diseasesInsights into the development of chemical probes for RNA
P2860
Q28821825-E77D6DF8-7AA2-473E-ACBE-E15CD0B9D495Q30276963-452EFF53-1CA9-42C5-A23D-6A5F3AEDA6E6Q37624658-30513A4D-5930-4667-B58B-0F976DC03E0FQ38806729-EA47EDF1-CF02-43F9-94E2-D9A024E6E9B7Q38840111-1ACDAC0E-9A50-43F8-BB11-C482475F25BCQ38855524-432A9FCB-16D1-4E61-A0DD-6F66E4325D7FQ38882829-883C570D-1054-499F-A5E4-30C7BFF95E6FQ47164513-7AF021CB-95D7-4173-B7F2-CC8AB527484BQ47384523-CC009F18-E831-47B1-8103-67287AA8E601Q47569012-EFCE6896-71ED-4C6D-8DC5-D82D0CF1628BQ48145230-1379FC14-659C-4A9A-9858-B254E46A2B07Q48236350-415FA72B-C238-4E11-973C-2A3EE15CDFCCQ48237461-FC26DA26-6644-4621-BC55-0FF74398884DQ48434911-9F8C1CB3-06D0-4FF8-8CD4-BE8BCB11CDA5Q55648829-22E4980D-A9EB-438C-BE3A-B072C0B32E50Q58743091-49C04BBC-8F46-4E3E-8EFB-11B2DAA1A091Q58794879-DE9EE76B-D8DA-49A9-BDA9-ECAE5A158418
P2860
RNA Structures as Mediators of Neurological Diseases and as Drug Targets.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
RNA Structures as Mediators of Neurological Diseases and as Drug Targets.
@ast
RNA Structures as Mediators of Neurological Diseases and as Drug Targets.
@en
type
label
RNA Structures as Mediators of Neurological Diseases and as Drug Targets.
@ast
RNA Structures as Mediators of Neurological Diseases and as Drug Targets.
@en
prefLabel
RNA Structures as Mediators of Neurological Diseases and as Drug Targets.
@ast
RNA Structures as Mediators of Neurological Diseases and as Drug Targets.
@en
P2860
P1433
P1476
RNA Structures as Mediators of Neurological Diseases and as Drug Targets.
@en
P2093
Matthew D Disney
P2860
P356
10.1016/J.NEURON.2015.06.012
P407
P577
2015-07-01T00:00:00Z